Cabot Corporation $CBT Shares Sold by Eastern Bank

Eastern Bank decreased its stake in shares of Cabot Corporation (NYSE:CBT) by 3.4% during the 3rd quarter, Holdings Channel.com reports. The firm owned 238,845 shares of the specialty chemicals company’s stock after selling 8,298 shares during the period. Eastern Bank’s holdings in Cabot were worth $18,164,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in CBT. NewEdge Advisors LLC increased its stake in shares of Cabot by 2,559.5% during the first quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock worth $82,000 after buying an additional 947 shares during the period. Goldman Sachs Group Inc. grew its holdings in Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after acquiring an additional 108,645 shares in the last quarter. Empowered Funds LLC grew its holdings in Cabot by 102.6% during the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock worth $2,341,000 after acquiring an additional 14,260 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Cabot by 3.4% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after purchasing an additional 4,048 shares during the last quarter. Finally, Intech Investment Management LLC raised its holdings in shares of Cabot by 54.9% in the 1st quarter. Intech Investment Management LLC now owns 30,405 shares of the specialty chemicals company’s stock valued at $2,528,000 after purchasing an additional 10,775 shares in the last quarter. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Stock Performance

NYSE CBT opened at $71.59 on Wednesday. The company has a fifty day moving average of $65.22 and a two-hundred day moving average of $72.18. The company has a market capitalization of $3.79 billion, a PE ratio of 11.91, a P/E/G ratio of 3.83 and a beta of 0.89. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $92.89. The company has a debt-to-equity ratio of 0.50, a current ratio of 1.61 and a quick ratio of 1.08.

Cabot (NYSE:CBT) last posted its earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 earnings per share for the quarter, missing the consensus estimate of $1.72 by ($0.02). The firm had revenue of $899.00 million during the quarter, compared to analysts’ expectations of $967.02 million. Cabot had a net margin of 8.91% and a return on equity of 24.55%. The firm’s revenue for the quarter was down 10.2% on a year-over-year basis. During the same period in the previous year, the firm posted $1.80 earnings per share. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. As a group, analysts expect that Cabot Corporation will post 7.57 earnings per share for the current year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 12th. Stockholders of record on Friday, November 28th were given a dividend of $0.45 per share. The ex-dividend date was Friday, November 28th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 2.5%. Cabot’s dividend payout ratio (DPR) is 29.95%.

Wall Street Analyst Weigh In

A number of equities analysts recently commented on CBT shares. JPMorgan Chase & Co. lowered their target price on shares of Cabot from $75.00 to $54.00 and set an “underweight” rating for the company in a research note on Friday, November 28th. Mizuho lifted their price target on Cabot from $72.00 to $80.00 and gave the stock an “outperform” rating in a report on Thursday, December 18th. UBS Group upped their price objective on Cabot from $65.00 to $74.00 and gave the stock a “neutral” rating in a research report on Monday. Zacks Research lowered Cabot from a “hold” rating to a “strong sell” rating in a research report on Friday, November 7th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, Cabot has a consensus rating of “Hold” and a consensus price target of $72.25.

Cabot Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.